OMIC-03. TRANSLATIONAL CONTROL IN MYC AND MYCN MEDULLOBLASTOMA. Read more about OMIC-03. TRANSLATIONAL CONTROL IN MYC AND MYCN MEDULLOBLASTOMA.
Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors. Read more about Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.
Functional connectivity within glioblastoma impacts overall survival. Read more about Functional connectivity within glioblastoma impacts overall survival.
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank. Read more about Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR. Read more about A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.
HGG-01. ENTRECTINIB IN RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS: UPDATED DATA IN CHILDREN AND ADOLESCENTS. Read more about HGG-01. ENTRECTINIB IN RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS: UPDATED DATA IN CHILDREN AND ADOLESCENTS.
Diffusion MRI as an early marker of response to immune checkpoint inhibitors. Read more about Diffusion MRI as an early marker of response to immune checkpoint inhibitors.
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C. Read more about Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C.
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence. Read more about MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence.
European genetic ancestry associated with risk of childhood ependymoma. Read more about European genetic ancestry associated with risk of childhood ependymoma.
